According to Mikael Dolsten, Pfizer’s chief scientific officer, the company’s boosters will reach individuals who are at a higher risk of developing severe illness, complications, hospital admission and death by COVID. This includes seniors and people with certain underlying conditions.
“We cannot, of course, predict what CDC and similar agencies will do,” Dolsten said. He stated that, in his opinion, booster rollout “would likely start with those that are most susceptible, older adults, those with chronic diseases such as cardiovascular, obesity, COPD, asthma, many that are immune-impaired. And of course, that constitutes a very large population.”
While there isn't any cure for cancer yet, we can definitely keep it at bay… READ ON
Macronutrients...it sounds funny, right? I mean, we barely understand things about nutrients...let alone about MACROnutrients!… READ ON
China is a popular destination for its fine cuisine and numerous dishes. Even so, some… READ ON
Sometimes, last night's dinner is a real-life saver when you need a hot and ready… READ ON
If you don't know already that breakfast is the most important meal of the day,… READ ON
Although some of us might love it, eating too much sugar can affect our health.… READ ON